share_log

亨迪药业(301211.SZ):托拉塞米片通过仿制药一致性评价

Hendy Pharmaceuticals (301211.SZ): Torasemide tablets pass generic drug consistency evaluation

Gelonghui Finance ·  May 16 04:28

Gelonghui, May 16 | Hendi Pharmaceutical (301211.SZ) announced that the company recently received the “Drug Supplement Application Approval Notice” for torasemide tablets (hereinafter referred to as “drugs”) approved and issued by the State Drug Administration. The company's torasemide tablets are cardiovascular drugs, mainly used for edema associated with high blood pressure, chronic congestive heart failure, liver cirrhosis, ascites, and nephrotic syndrome.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment